✅ Model Answer:
• Diagnosis: Refsum disease — a peroxisomal disorder characterized by impaired alpha-oxidation of phytanic acid, leading to its accumulation. Clinical triad: progressive ataxia, retinitis pigmentosa (night blindness, color vision difficulty), and sensorineural hearing loss. Ichthyosis (scaly skin) is a classic feature. Elevated phytanic acid and cerebellar atrophy on MRI are supportive.
• Any other test: Elevated Phytanic Acid, Genetic testing for PHYH or PEX7 mutations (confirmatory), nerve conduction studies (demyelinating neuropathy), ophthalmology evaluation (retinitis pigmentosa, visual field testing), audiometry, ECG (cardiac conduction defects).
• What to do next: Start dietary restriction of phytanic acid (avoid green vegetables, dairy, beef fat, fish). Plasmapheresis if severely elevated. Multidisciplinary care: neurology, ophthalmology, audiology, dermatology.
• Follow-up plan: Monitor phytanic acid levels, vision, hearing, neurologic exam. Prognosis: improved with dietary restriction; progressive if untreated.

✅ Model Answer:
• Refsum disease (classic Refsum disease) is a rare autosomal recessive peroxisomal disorder caused by impaired alpha-oxidation of phytanic acid.
• Genes:
- PHYH (phytanoyl-CoA hydroxylase) — most common (90% of cases).
- PEX7 (peroxin 7) — less common, associated with more severe phenotypes.
• Protein: Phytanoyl-CoA hydroxylase is responsible for the first step in phytanic acid degradation (alpha-oxidation).
• Pathophysiology: Phytanic acid (a branched-chain fatty acid) accumulates in tissues (brain, retina, peripheral nerves, skin, heart) → progressive neurologic and systemic damage.
• Prevalence: Rare (1 in 1,000,000).
• Inheritance: Autosomal recessive (both parents are carriers).

✅ Model Answer:
• Classic tetrad (core features):
- Retinitis pigmentosa: Night blindness, progressive visual field loss, color vision impairment, eventually blindness.
- Sensorineural hearing loss: Progressive hearing loss (often bilateral).
- Ataxia: Cerebellar ataxia (gait, limb, truncal).
- Peripheral neuropathy: Demyelinating neuropathy (weakness, sensory loss, areflexia).
- Ichthyosis: Scaly, dry skin (hyperkeratosis).
• Other features:
- Cardiac: Arrhythmias, cardiomyopathy.
- Skeletal: Pes cavus, scoliosis.
- Optic atrophy: Progressive vision loss.
- Anosmia: Loss of smell.
- Neurologic: Cognitive decline, spasticity, dystonia (rare).
- Age of onset: Variable — usually childhood to adolescence (5-15 years).

✅ Model Answer:
• Phytanic acid: A branched-chain fatty acid derived from dietary sources (green vegetables, dairy, beef fat, fish).
• Normal metabolism: Phytanic acid is degraded by alpha-oxidation in peroxisomes.
• In Refsum disease: Alpha-oxidation is impaired (PHYH or PEX7 mutations) → phytanic acid accumulates in tissues and plasma.
• Plasma phytanic acid: Elevated in Refsum disease (normal <10 µmol/L; patients may have >200-500 µmol/L).
• Diagnostic: Elevated plasma phytanic acid + clinical features = Refsum disease.
• Monitoring: Phytanic acid levels are used to monitor treatment response (dietary restriction).
• Dietary: Phytanic acid is exclusively obtained from diet — dietary restriction can reduce levels.

✅ Model Answer:
• MRI Brain findings:
- Cerebellar atrophy: Vermian and hemispheric atrophy (most common).
- White matter changes: T2/FLAIR hyperintensities in cerebral and cerebellar white matter.
- Brainstem involvement: Atrophy of the pons and medulla (in advanced cases).
- Corpus callosum: May show thinning.
- No specific pattern: Variable findings depending on disease severity.
• Progression: Cerebellar atrophy and white matter changes worsen over time.
• Differentiation: Helps differentiate Refsum disease from other metabolic ataxias (e.g., mitochondrial disorders, GLUT1 deficiency).
• Role: Supports diagnosis but is not specific; genetic testing is confirmatory.

✅ Model Answer:
• Dietary restriction of phytanic acid: The cornerstone of treatment.
- Avoid: Green vegetables (spinach, cabbage, broccoli), dairy products (milk, cheese, butter), beef fat, fish (especially fatty fish), lamb, and other ruminant animal products.
- Allowed: Poultry, eggs, fruits, grains, non-ruminant meats.
- Goal: Reduce plasma phytanic acid levels to <20 µmol/L.
- Monitoring: Regular plasma phytanic acid levels.
• Plasmapheresis: If phytanic acid levels are severely elevated (>500 µmol/L) or if neurologic symptoms are rapidly progressive.
• Multidisciplinary care:
- Neurology: Monitor ataxia, neuropathy.
- Ophthalmology: Monitor retinitis pigmentosa, visual fields.
- Audiology: Monitor hearing loss.
- Dermatology: Manage ichthyosis (emollients).
- Cardiology: Monitor for arrhythmias, cardiomyopathy.
- Physical therapy: Gait training, mobility aids.
• Genetic counseling: Autosomal recessive (25% recurrence risk for siblings).

✅ Model Answer:
• Complications:
- Progressive ataxia: Leads to wheelchair dependence in adulthood.
- Retinitis pigmentosa: Progressive vision loss → legal blindness.
- Sensorineural hearing loss: Progressive deafness.
- Peripheral neuropathy: Weakness, sensory loss, areflexia.
- Cardiac arrhythmias: Due to fatty acid accumulation in the heart — can be life-threatening.
- Cardiomyopathy: Dilated or hypertrophic cardiomyopathy.
- Ichthyosis: Dry, scaly skin — may be disfiguring.
- Death: Usually from cardiac arrhythmias or complications of progressive neurologic disease.
- If untreated: Progressive neurologic decline and death by 30-50 years.
- With dietary restriction: Improved survival and slower progression.

✅ Model Answer:
• Prognosis:
- Variable: Depends on age of onset, severity of symptoms, and compliance with dietary restriction.
- With dietary restriction: Slower progression, improved survival.
- Without dietary restriction: Progressive neurologic decline, cardiac arrhythmias, death by 30-50 years.
- Cardiac arrhythmias: Main cause of death (sudden cardiac death).
- Quality of life: Can be maintained with early diagnosis and treatment.
- Life expectancy: Improved with treatment (may survive into 60s).
• Long-term follow-up:
- Monitor phytanic acid levels: Regularly (goal <20 µmol/L).
- Cardiology: Annual ECG and echocardiogram (monitor for arrhythmias and cardiomyopathy).
- Ophthalmology: Annual visual field testing, fundoscopy.
- Audiology: Annual hearing tests.
- Neurology: Annual neurologic exams.
- Dermatology: Skin care for ichthyosis.
- Genetic counseling: For family members (autosomal recessive, 25% recurrence).
- Dietitian: Ongoing nutritional support.